EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advantages of Remimazolam in Pediatric Anesthesia: A Narrative Review

Alessandro Vittori iD, Cecilia Di Fabio, Elisa Francia iD, Ilaria Mascilini iD, Riccardo Tarquini iD, Corrado Cecchetti, Giuliano Marchetti iD, Franco Marinangeli iD, Teresa Grimaldi Capitello iD, Marco Cascella iD

Children · 27.02.2026 · 13 (3) · 348

DOI: 10.3390/children13030348 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Children, online erschienen am 27.02.2026. Verfasst von Alessandro Vittori und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Critical Care and Pain Medicine, ARCO, Ospedale Pediatrico Bambino Gesù IRCCS, Piazza S. Onofrio 4, 00165 Rome, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Remimazolam is an ultra-short-acting benzodiazepine developed according to the “soft drug” concept and characterized by rapid onset, predictable offset, organ-independent metabolism, and the availability of a specific antagonist. Due to these pharmacological features, this drug represents a particularly attractive option for pediatric anesthesia and sedation, a field in which traditional agents are often limited by hemodynamic instability, prolonged recovery, and adverse respiratory effects. This narrative review summarizes and discusses the current evidence regarding the use of remimazolam in pediatric patients, focusing on pharmacokinetics, pharmacodynamics, clinical applications, and safety. Available data indicate that remimazolam provides effective sedation and anesthesia in children across multiple settings, including induction of general anesthesia, non-operating room anesthesia, and intensive care unit sedation. Compared with propofol and midazolam, remimazolam is generally associated with greater hemodynamic stability, rapid recovery, reduced emergence delirium, and a favorable respiratory profile, while maintaining comparable efficacy. Intranasal administration has also shown promise as a premedication strategy for reducing preoperative anxiety, although it may occasionally be associated with pain. Even if remimazolam lacks intrinsic analgesic properties, its use appears to indirectly improve postoperative comfort by attenuating stress responses and emergence agitation. Despite encouraging results, pediatric use of remimazolam remains off-label in many countries, and evidence is still limited by small sample sizes and heterogeneous protocols. Further large-scale randomized controlled trials are needed to define optimal dosing strategies, long-term safety, and their definitive role in pediatric anesthetic and sedative practice.

Schlagwörter

Stichwörter der Autor:innen

anesthesiaanxietychildrenintensive care unitnon-operative room anesthesiaopioidpainpediatric anesthesiaremimazolamsedation

Autor:innen und Institutionen

  • Department of Anesthesia, Critical Care and Pain Medicine, ARCO, Ospedale Pediatrico Bambino Gesù IRCCS, Piazza S. Onofrio 4, 00165 Rome, Italy.
  • Department of Life, Health and Environmental Sciences (MeSVA), University of L'Aquila, Piazzale Salvatore Tommasi 1, Blocco 11, 67010 L'Aquila, Italy.
  • Surgery Unit, Bios Medical Center, Via Domenico Chelini 39, 00197 Rome, Italy.
  • Clinical Psychology Unit, Department of Neuroscience, Ospedale Pediatrico Bambino Gesù IRCCS, Piazza S. Onofrio 4, 00165 Rome, Italy.
  • Department of Medicine, Surgery and Dentistry, University of Salerno, Via Salvador Allende, 43, 84081 Baronissi, Italy.

ORCID-Profile: Alessandro Vittori, Elisa Francia, Ilaria Mascilini, Riccardo Tarquini, Giuliano Marchetti, Franco Marinangeli, Teresa Grimaldi Capitello, Marco Cascella

Zitieren

APA

Vittori, A., Di Fabio, C., Francia, E., Mascilini, I., Tarquini, R., Cecchetti, C., Marchetti, G., Marinangeli, F., Grimaldi Capitello, T., & Cascella, M. (2026). Advantages of Remimazolam in Pediatric Anesthesia: A Narrative Review. Children, 13(3), 348. https://doi.org/10.3390/children13030348

Vancouver

Vittori A, Di Fabio C, Francia E, Mascilini I, Tarquini R, Cecchetti C, et al. Advantages of Remimazolam in Pediatric Anesthesia: A Narrative Review. Children. 2026;13(3):348. doi:10.3390/children13030348

BibTeX
@article{Vittori2026,
  author = {Vittori, Alessandro and Di Fabio, Cecilia and Francia, Elisa and Mascilini, Ilaria and Tarquini, Riccardo and Cecchetti, Corrado and Marchetti, Giuliano and Marinangeli, Franco and Grimaldi Capitello, Teresa and Cascella, Marco},
  title = {Advantages of Remimazolam in Pediatric Anesthesia: A Narrative Review},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {348},
  doi = {10.3390/children13030348}
}
Kostenlos starten →